These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18836880)

  • 1. Molecular weight of polydisperse icodextrin effects its oncotic contribution to water transport.
    Nishimura K; Kamiya Y; Miyamoto K; Nomura S; Horiuchi T
    J Artif Organs; 2008; 11(3):165-9. PubMed ID: 18836880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
    Akonur A; Holmes CJ; Leypoldt JK
    Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of osmotic and oncotic factors on gentamicin and insulin transport across the peritoneal membrane in vitro.
    Grzelak T; Wojciechowska K; Szary B; Czyzewska K
    Adv Perit Dial; 2011; 27():16-21. PubMed ID: 22073822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
    Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
    Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.
    Morelle J; Sow A; Fustin CA; Fillée C; Garcia-Lopez E; Lindholm B; Goffin E; Vandemaele F; Rippe B; Öberg CM; Devuyst O
    J Am Soc Nephrol; 2018 Jul; 29(7):1875-1886. PubMed ID: 29844208
    [No Abstract]   [Full Text] [Related]  

  • 6. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.
    Leypoldt JK; Hoff CM; Akonur A; Holmes CJ
    Perit Dial Int; 2015; 35(4):428-35. PubMed ID: 24584616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
    Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
    Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.
    Stachowska-Pietka J; Waniewski J; Olszowska A; Garcia-Lopez E; Wankowicz Z; Lindholm B
    Sci Rep; 2023 Apr; 13(1):6526. PubMed ID: 37085652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of hyaluronan on peritoneal permeability for macromolecules in vitro].
    Grzelak T; Czyzewska K; Szary B
    Pol Arch Med Wewn; 2005 Dec; 114(6):1163-71. PubMed ID: 16789485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children.
    Rusthoven E; Krediet RT; Willems HL; Monnens LA; Schröder CH
    J Am Soc Nephrol; 2004 Nov; 15(11):2940-7. PubMed ID: 15504948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal transport dynamics of glucose and icodextrin: the in vitro comparative studies.
    Czyzewska K; Szary B; Grzelak T
    Adv Perit Dial; 2005; 21():53-8. PubMed ID: 16686284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icodextrin peritoneal transport in vitro: effect of sodium deoxycholate, glucose, and methylglyoxal.
    Szary B; Grzelak T; Czyzewska K
    Artif Organs; 2007 Feb; 31(2):140-7. PubMed ID: 17298403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid assay for icodextrin determination in plasma and dialysate.
    Wang R; Moberly JB; Martis L; Shockley TR; Mongoven JW; Patel H; Kunzler J; Hughes G; Gass J
    Adv Perit Dial; 2002; 18():91-5. PubMed ID: 12402596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of cefepime in icodextrin peritoneal dialysis solution.
    Elwell RJ; Volino LR; Frye RF
    Ann Pharmacother; 2004 Dec; 38(12):2041-4. PubMed ID: 15494381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.